China Adds Risk‑Based Payments for Tough TB Cases
In China, treating tuberculosis that resists standard drugs is harder and costs more than usual cases. Until recently, the national payment system did not account for this extra difficulty. A pilot city in 2022 changed that rule by adding a risk adjustment to its diagnosis‑intervention packet pay